Clik here to view.
Better-Than-Expected DJIA Dividend Surprise from Johnson & Johnson
We have now seen three Dow Jones Industrial Average components raise their dividend payouts to shareholders this week. The third is Johnson & Johnson (NYSE: JNJ), which has just declared an...
View ArticleClik here to view.
PropThink Analyst Finds Five Cheap Biotech Stocks to Buy
Biotech investing has always proven to be a slippery slope. It is one thing to own one of the large-cap biotech stocks, but it can be a challenge when looking for the stocks that have the potential to...
View ArticleClik here to view.
After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma...
Biotech stocks come and go as far as the flavor of the day for investors. While many of these companies are risky, and while many are too risky for many investors, what investors need to know is that...
View ArticleClik here to view.
The Top Seven Drugs with U.S. Quarterly Sales Over $1 Billion
The world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating billions upon billions in annual sales in the United States alone. Some of these...
View ArticleClik here to view.
Workers Taking the Most Sick Days
Sick days are estimated to cost the U.S. economy $84 billion each year. According to the latest data released in a joint study by Gallup and Healthways, some professions miss substantially more time...
View ArticleClik here to view.
Dendreon Shows Poor Provenge Sales, Implosion Risk Rising
Dendreon Corp. (NASDAQ: DNDN) just cannot catch a break. Despite having what was supposed to be one of the best late-stage prostate treatments in Provenge, sales just are not coming in as expected....
View ArticleClik here to view.
Jefferies Stocks to Buy: Big Gains in Life Sciences and Diagnostics
In theory, medical technology companies should be some of the market’s best-performing stocks. After all, it’s not really a cyclical business, and price tags are rarely a stumbling block when insurance...
View ArticleClik here to view.
Myriad Genetics, Angelina Jolie and Genomics in Focus
Myriad Genetics Inc. (NASDAQ: MYGN) is seeing a benefit in its share price after actress Angelina Jolie wrote that a genetic test using Myriad’s gene sequencing tested positive for the gene with much...
View ArticleClik here to view.
Deutsche Bank Firm on Biotech Stocks to Buy
Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the 28% gain for the...
View ArticleClik here to view.
Dendreon Gets Prostate Cancer Competition for Provenge from Bayer’s Xofigo
Dendreon Corp. (NASDAQ: DNDN) has been facing problems getting its Provenge sales for advanced metastatic prostate cancer through to the market. Even a direct to consumer advertising campaign has so...
View ArticleClik here to view.
States with the Most Americans on Disability
The number of Americans receiving Social Security Disability Insurance (SSDI) more-than doubled over the past two decades, from 5.2 million to 11.7 million by the end of 2011. The number of residents...
View ArticleClik here to view.
Herbalife Stock Halted Briefly as New Audit Firm Named
Shares of Herbalife Ltd. (NYSE: HLF) were halted briefly shortly before noon today as we all waited breathlessly for news. When the new arrived, well, how exciting can a new auditing firm be? That’s...
View ArticleClik here to view.
PropThink Biotech Stocks to Buy with Big Gains: Cubist, Immunomedics and More
The world of biotech investing is always a difficult one. Often a binary event, such as U.S. Food and Drug Administration (FDA) approval or a life-saving capital raise, is the difference between not...
View ArticleClik here to view.
Yet Another 1999 or 2000 Bull Market Stock Split
Cerner Inc. (NASDAQ: CERN) is acting like the stock market is back to 1999 or 2000 all over again. Now that the healthcare solutions provider’s shares are up more than 20% so far in 2013 alone and...
View ArticleClik here to view.
The Happiest Countries in the World
The residents of Switzerland are the most satisfied with their lives, according to the latest Better Life Index report, released this week by the Organization for Economic Co-operation and Development...
View ArticleClik here to view.
Top Stocks That May Move Big at Jefferies Global Healthcare Conference
Once again, the Wall Street conference calendar is heating up. Next week is the widely attended Jefferies Global Healthcare Conference in New York City. Following the success of last year’s conference,...
View ArticleClik here to view.
Cellular Dynamics Files For IPO, Wholesale Human Cells For Sale!
Another company IPO filing has been on Monday from Cellular Dynamics International, Inc. No financial terms have been set, but the filing is for up to $57,250,000 worth of common sock. The company has...
View ArticleClik here to view.
What Affordable Care Woes? UnitedHealth Boosts Dividend, Launches Huge Share...
UnitedHealth Group, Inc. (NYSE: UNH) is the largest health insurance provider in America. That makes it a number one target of the so-called affordable health care, or Obamacare, along with the other...
View ArticleClik here to view.
Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy
As the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their coverage...
View ArticleClik here to view.
Big Implied Upside for Ambit as Analyst Quiet Period Ends
Ambit Biosciences Corp. (NASDAQ: AMBI) has been somewhat tame since its recent initial public offering (IPO). Its quiet period has ended and the analyst community is looking past a poor post-IPO...
View Article
